logo
Alloantibody and xenoantibody cross-reactivity in transplantation1
Programmed death-1–programmed death-L1 interaction is essential for induction of regulatory cells by intratracheal delivery of alloantigen
Adenoviral gene transfer of erythropoietin confers cytoprotection to isolated pancreatic islets
Predicting Outcome After Liver Transplantation: Utility of the Model for End-Stage Liver Disease and a Newly Derived Discrimination Function.
Expression of MRP2 and MRP3 during liver regeneration after 90% partial hepatectomy in rats1
Coronary oxygen persufflation for heart preservation in pigs: analyses of endothelium and myocytes1
Estrogen regulates insulin-like growth factor 1, platelet-derived growth factor A and B, and their receptors in the vascular wall
Donor hypertension increases graft immunogenicity and intensifies chronic changes in long-surviving renal allografts
The role of b7 ligands (cd80 and cd86) in cd152-mediated allograft tolerance: a crosscheck hypothesis
The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation1
High levels of C-reactive protein after simultaneous pancreas-kidney transplantation predict pancreas graft-related complications and graft survival
Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the familial amyloidotic polyneuropathy world transplant registry
Utility of transcranial doppler ultrasonography for confirmatory diagnosis of brain death: two sides of the coin
Epstein-barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy
Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C1
Is there disparity between risk and incidence of cardiovascular disease after liver transplant?
Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function1
Impact of evolving trends in recipient and donor characteristics on cytomegalovirus infection in liver transplant recipients1
Long-term follow-up of percutaneous transhepatic balloon cholangioplasty in the management of biliary strictures after liver transplantation
Topical photodynamic therapy in the treatment of actinic keratoses and Bowen’s disease in transplant recipients
Identification, cloning, and characterization of a novel rat natural killer receptor, RNKP30: a molecule expressed in liver allografts
Thrombotic microangiopathy associated with combined sirolimus and tacrolimus immunosuppression after intestinal transplantation
Retransplantation in patients with graft loss caused by polyoma virus nephropathy
Effects of sinus surgery in patients with cystic fibrosis after lung transplantation: a 10-year experience
Liver transplantation using an organ donor with HELLP syndrome
Subcutaneous black fungus (phaeohyphomycosis) infection in renal transplant recipients:three cases
The development of new density gradient media for purifying human islets and islet-quality assessments
Renal cell carcinoma of the grafted kidney: how to improve screening and graft tracking
Organ donation: altruism or self interest?
A bridge between hearts: mutual organ donation by Arabs and Jews in Israel
Commentary on “a bridge between hearts”
Increasing Organ Transplantation—Fairly
Incentives to promote organ donation
TOWARD CALCINEURIN ANTAGONIST MINIMIZATION
EARLY WITHDRAWAL OF CYCLOSPORINE IMPROVES 1-YEAR KIDNEY GRAFT STRUCTURE AND FUNCTION IN SIROLIMUS-TREATED PATIENTS: RESPONSE TO THE AUTHORS